CCL5 and hyper-IgE syndrome: These findings indicate the compromised binding of STAT3 and NF-κB p50 to the RANTES promoter in patients with HIES, and this compromised binding is attributed to the reduced pSTAT3 levels, which are acting as its own regulator.